Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac myocytes (cardiomyocytes) are the contractile muscle cells of the heart myocardium, responsible for the coordinated contractions that pump blood. They are characterized by high expression of sarcomere proteins (e.g., TTN, MYBPC3, TNNT2), advanced calcium-handling machinery, and abundant mitochondria to meet intense energy demands [1][3][5]. While current therapies for heart disease often modulate molecular targets within cardiac myocytes (such as ion channels or signaling pathways), the cardiac myocyte itself is not a singular molecular target but a cell type integral to heart function and disease pathophysiology. Dysfunction or loss of cardiac myocytes underlies many forms of heart failure and cardiomyopathy, and new therapeutic approaches (such as stem cell or exosome therapy) aim to restore or protect these cells [4][6].
Modulation of ion channels (e.g., sodium, calcium, potassium channels); Modulation of adrenergic signaling (by beta-blockers); Inhibition of calcium influx (by calcium channel blockers); Influence on gene transcription/signaling pathways (e.g., via PKC, PI3K/Akt)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac myocyte.